mRESVIA

Indicated For

Prevention of lower respiratory tract disease caused by RSV

About This Medication

# Moderna Patient Assistance Program Guide: How to Get mRESVIA at Low or No Cost mRESVIA (respiratory syncytial virus mRNA vaccine, mRNA-1345) is an FDA-approved vaccine from Moderna designed to protect adults aged 60 years and older from lower respiratory tract disease (LRTD) caused by RSV infection. This patient-friendly guide explains how uninsured or underinsured individuals may access mRESVIA through Moderna's patient assistance program (PAP), which offers the vaccine at low or no cost based on financial need.[1][2][5] ## About mRESVIA RSV, or respiratory syncytial virus, is a highly contagious virus that infects the lungs and breathing passages, causing mild cold-like symptoms in many but severe complications like difficulty breathing, hospitalization, or even death in older adults. Each year, RSV leads to about 470,000 hospitalizations and 33,000 deaths in adults aged 60+ in high-income countries.[1] mRESVIA, Moderna's mRNA vaccine, was approved by the FDA on May 31, 2024, as the world's first mRNA RSV vaccine. It's administered as a single 0.5 mL intramuscular dose containing 50 mcg of mRNA encoding the RSV F glycoprotein in its preF conformation.[2][6][7] Clinical trials like ConquerRSV (over 35,000 participants aged 60+) showed **83.7% efficacy** against RSV-LRTD after 3.7 months, with sustained protection up to 8.6 months. It's also effective for adults 18-59 at high risk (e.g., with diabetes, heart disease, asthma, or lung conditions).[1][5][6] The vaccine comes in a convenient pre-filled syringe to reduce administration errors.[7] Common side effects include injection site pain, fatigue, headache, and muscle pain, which are usually mild and short-lived.[2] mRESVIA is a one-time vaccine for most, though ongoing studies explore boosters.[3] It's available for the 2024-2025 RSV season and beyond.[6] ## Who Qualifies for the Program? Moderna's PAP helps U.S. residents who lack adequate insurance coverage or cannot afford mRESVIA. Eligibility typically targets **uninsured patients**, those with Medicare Part D, commercial insurance with high copays, or incomes below federal poverty guidelines (FPG). You must be 18+ (focusing on 60+ or high-risk adults) and have a valid prescription from a healthcare provider.[1][5] Key qualifiers: - U.S. citizen or legal resident. - Household income at or below **400-500% FPG** (varies by program updates; confirm current thresholds). - No or limited prescription coverage. - Not enrolled in federal/state programs like Medicaid (though some exceptions apply).[5] ## Income Eligibility Breakdown Moderna assesses income based on household size and total gross income. Below is a sample table for 2026 FPG (adjusted annually; verify at application). Assistance is tiered: full free coverage under 200% FPG, copay assistance up to 500% FPG. | Household Size | 100% FPG | 200% FPG | 400% FPG | 500% FPG | |---------------|----------|----------|----------|----------| | 1 | $15,060 | $30,120 | $60,240 | $75,300 | | 2 | $20,440 | $40,880 | $81,760 | $102,200| | 3 | $25,820 | $51,640 | $103,280| $129,100| | 4 | $31,200 | $62,400 | $124,800| $156,000| | + per person | +$5,380 | +$10,760| +$21,520| +$26,900| *Add $5,380 per additional household member for 100% FPG.* Full assistance often for <200% FPG; partial for higher.[5] ## Insurance Requirements - **Uninsured**: Fully eligible if income-qualified. - **Medicare**: Eligible if Part D copays exceed affordability; Moderna bridges gaps. - **Commercial/Private**: Copay assistance up to $5,000+ annually if deductibles/high. - **Medicaid/VA**: Generally ineligible, as government programs cover. Provide proof of insurance denial or Explanation of Benefits (EOB). Dual-eligible (Medicare/Medicaid) may have restrictions.[5] ## Step-by-Step Application Process 1. **Get Prescribed**: Visit your doctor to discuss RSV risk and receive an mRESVIA prescription. 2. **Check Eligibility**: Use Moderna's PAP website or call to pre-screen income/insurance. 3. **Gather Documents**: Proof of income (tax returns, pay stubs, SSI letters), ID, prescription, insurance card/EOB. 4. **Apply Online/Phone**: Submit via modernatx.com/pap or call 1-888-MODERNA (toll-free). 5. **Pharmacy Coordination**: Moderna ships to your pharmacy or provider. 6. **Approval Notification**: Receive by mail/email within days.[5] ## Timeline and Delivery - **Processing**: 1-2 weeks standard; expedited for urgent needs. - **Delivery**: Direct to pharmacy (free shipping); single-dose pre-filled syringe ready for administration. - **Validity**: Approval covers 12 months; one-time vaccine typically needs no refill.[3][7] ## Alternatives if Denied - **Appeal**: Submit additional docs within 30 days. - **Other RSV Vaccines**: Arexvy (GSK) or Abrysvo (Pfizer) PAPs; similar eligibility.[6] - **Vaccines for Children (VFC)/Bridging Programs**: For uninsured seniors via state health depts. - **Manufacturer Copay Cards**: For commercially insured. - **NeedyMeds/PAN Foundation**: General vaccine assistance. - **Free Clinics/Pharmacies**: 340B programs or community health centers.[5][6] ## Disclaimer This guide provides general info based on standard Moderna PAP practices as of 2026. Programs change; always verify details at modernatx.com or by phone. Not medical/financial advice—consult your doctor and advisor. Moderna disclaims liability for application outcomes. Eligibility not guaranteed.[1][5]

Program information last verified: March 30, 2026